Technical Analysis for NSB - NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD

Grade Last Price % Change Price Change
D 0.048 -7.69% -0.004
NSB closed down 7.69 percent on Friday, April 26, 2024, on 43 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Flat Down

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -7.69%
Outside Day Range Expansion -7.69%
Wide Bands Range Expansion -7.69%
Oversold Stochastic Weakness -7.69%
Boomer Buy Setup Bullish Swing Setup -7.69%
Narrow Range Bar Range Contraction -7.69%

   Recent Intraday Alerts

Alert Time
Fell Below 50 DMA about 18 hours ago
50 DMA Support about 21 hours ago
Down 5% about 21 hours ago
1.5x Volume Pace about 21 hours ago
Fell Below Previous Day's Low about 21 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NeuroScientific Biopharmaceuticals Ltd is an Australia-based pharmaceutical company. The Company develops peptide-based drugs that target neurodegenerative conditions. The Company’s product portfolio consists of EmtinB, 15mS.A, and other Emtin peptides. EmtinB is the Company’s lead therapeutic peptide candidate targeting Alzheimer's disease. 15mS.A. is a diagnostic peptide foe early-stage Alzheimer’s disease. Other Emtin peptides include EmtinAc, EmtinAn, and EmtinBn that demonstrates similar therapeutic properties as EmtinB.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Disease Drugs Pharmaceuticals Biopharmaceutical Neuroscience Peptide Peptides Alzheimer's Disease Neurodegeneration

Is NSB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.14
52 Week Low 0.035
Average Volume 874,426
200-Day Moving Average 0.068
50-Day Moving Average 0.048
20-Day Moving Average 0.057
10-Day Moving Average 0.056
Average True Range 0.005
RSI (14) 44.44
ADX 31.51
+DI 30.048
-DI 27.981
Chandelier Exit (Long, 3 ATRs) 0.065
Chandelier Exit (Short, 3 ATRs) 0.056
Upper Bollinger Bands 0.070
Lower Bollinger Band 0.044
Percent B (%b) 0.15
BandWidth 45.534
MACD Line 0.001
MACD Signal Line 0.003
MACD Histogram -0.0019
Fundamentals Value
Market Cap 4.18 Million
Num Shares 87.2 Million
EPS -0.02
Price-to-Earnings (P/E) Ratio -2.09
Price-to-Sales 0.00
Price-to-Book 7.40
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.053
Resistance 3 (R3) 0.053 0.052 0.052
Resistance 2 (R2) 0.052 0.051 0.052 0.051
Resistance 1 (R1) 0.050 0.050 0.050 0.050 0.051
Pivot Point 0.049 0.049 0.049 0.049 0.049
Support 1 (S1) 0.047 0.048 0.047 0.047 0.045
Support 2 (S2) 0.046 0.047 0.046 0.045
Support 3 (S3) 0.044 0.046 0.044
Support 4 (S4) 0.044